MCID: FBR003
MIFTS: 44

Fibrous Histiocytoma

Categories: Cancer diseases

Aliases & Classifications for Fibrous Histiocytoma

MalaCards integrated aliases for Fibrous Histiocytoma:

Name: Fibrous Histiocytoma 12 15
Histiocytoma, Benign Fibrous 44 73
Benign Fibrous Histiocytoma 12
Histiocytoma Fibrous 55
Fibroxanthoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4415
MeSH 44 D018219
NCIt 50 C3739
UMLS 73 C0206644

Summaries for Fibrous Histiocytoma

MalaCards based summary : Fibrous Histiocytoma, also known as histiocytoma, benign fibrous, is related to myxofibrosarcoma and malignant fibroxanthoma. An important gene associated with Fibrous Histiocytoma is ATF1 (Activating Transcription Factor 1), and among its related pathways/superpathways are Transcriptional misregulation in cancer and Striated Muscle Contraction. The drugs Doxorubicin and Mechlorethamine have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and lung.

Wikipedia : 76 Benign fibrous histiocytomas (also known as dermal dendrocytoma,dermatofibroma,fibrous... more...

Related Diseases for Fibrous Histiocytoma

Diseases related to Fibrous Histiocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 260)
# Related Disease Score Top Affiliating Genes
1 myxofibrosarcoma 32.4 DES FUS S100B
2 malignant fibroxanthoma 30.9 ACTC1 DES F13A1 S100B SERPINA3 VIM
3 myxoid chondrosarcoma 30.6 EWSR1 MTAP
4 liposarcoma 30.5 DES EWSR1 FUS VIM
5 granuloma annulare 30.4 F13A1 VIM
6 dedifferentiated liposarcoma 30.3 ACTC1 DES
7 myxoid liposarcoma 30.3 ATF1 EWSR1 FUS
8 cutaneous fibrous histiocytoma 29.9 ACTC1 CD163 DES F13A1 S100B SERPINA3
9 perineurioma 29.8 S100B VIM
10 histiocytoma 29.8 ATF1 CD163 CREB1 EWSR1 FUS MFHAS1
11 rhabdoid cancer 29.8 ACTC1 DES VIM
12 giant cell tumor 29.8 DES SERPINA3 VIM
13 chordoma 29.7 DES MTAP S100B VIM
14 congenital fibrosarcoma 29.6 ACTC1 DES VIM
15 fibromatosis 29.5 ACTC1 DES VIM
16 leiomyoma 29.4 ACTC1 DES VIM
17 embryonal sarcoma 29.3 DES S100B SERPINA3 VIM
18 gliosarcoma 29.2 ACTC1 S100B VIM
19 leiomyosarcoma 29.2 ACTC1 DES S100B VIM
20 histiocytosis 29.1 CD163 S100B SERPINA3
21 langerhans cell histiocytosis 29.0 CD163 F13A1 S100B
22 rhabdomyosarcoma 29.0 ACTC1 DES EWSR1 VIM
23 pleomorphic liposarcoma 28.9 ACTC1 DES S100B VIM
24 spindle cell sarcoma 28.9 ACTC1 DES S100B VIM
25 inflammatory myofibroblastic tumor 28.7 ACTC1 DES S100B VIM
26 hemangiopericytoma, malignant 28.0 ACTC1 DES F13A1 S100B VIM
27 dermatofibrosarcoma protuberans 27.7 ACTC1 DES F13A1 S100B SERPINA3 VIM
28 diaphyseal medullary stenosis with malignant fibrous histiocytoma 12.7
29 malignant fibrous histiocytoma of bone 12.4
30 malignant skin fibrous histiocytoma 12.2
31 histiocytoma, angiomatoid fibrous 12.2
32 benign deep fibrous histiocytoma 12.1
33 undifferentiated pleomorphic sarcoma 12.0
34 sclerosing hemangioma 11.9
35 tenosynovial giant cell tumor 11.2
36 pigmented villonodular synovitis 11.1
37 urachal cancer 11.1
38 sarcomatosis 10.8 ATF1 EWSR1
39 extraosseous chondrosarcoma 10.6 EWSR1 FUS
40 infantile digital fibromatosis 10.6 DES VIM
41 lymphangiomatosis 10.6 DES VIM
42 primitive neuroectodermal tumor of the cervix uteri 10.6 DES VIM
43 juxtacortical chondroma 10.6 EWSR1 FUS
44 atypical lipomatous tumor 10.6 FUS MFHAS1
45 sarcoma 10.6
46 melanoma of soft tissue 10.6 ATF1 CREB1 EWSR1
47 epulis 10.6 DES VIM
48 multicentric reticulohistiocytosis 10.5 F13A1 VIM
49 hydromyelia 10.5 S100B VIM
50 myofibroma 10.5 DES F13A1

Graphical network of the top 20 diseases related to Fibrous Histiocytoma:



Diseases related to Fibrous Histiocytoma

Symptoms & Phenotypes for Fibrous Histiocytoma

Drugs & Therapeutics for Fibrous Histiocytoma

Drugs for Fibrous Histiocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 101)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
2
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 51-75-2 4033
3
Ifosfamide Approved Phase 3,Phase 2,Phase 1,Not Applicable 3778-73-2 3690
4
Lenograstim Approved, Investigational Phase 3 135968-09-1
5
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
6
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
7
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
8
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
9
Dactinomycin Approved, Investigational Phase 3 50-76-0 2019 457193
10
Epirubicin Approved Phase 3 56420-45-2 41867
11
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
12
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1,Not Applicable 31703
13
Isophosphamide mustard Phase 3,Phase 2,Phase 1,Not Applicable 0
14 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
15 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
16 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable
17 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Not Applicable
18 Anti-Infective Agents Phase 3,Phase 2,Phase 1
19 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
20 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
21 Etoposide phosphate Phase 3,Phase 2
22 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
23 Antirheumatic Agents Phase 3,Phase 2,Phase 1
24 Antimitotic Agents Phase 3
25 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
26
Dacarbazine Approved, Investigational Phase 2 4342-03-4 5351166
27
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
28
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
29
Indinavir Approved Phase 2 150378-17-9 5362440
30
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
31
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
32
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
33
Everolimus Approved Phase 1, Phase 2 159351-69-6 6442177
34
Bevacizumab Approved, Investigational Phase 2 216974-75-3
35
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 5284616 6436030 46835353
36
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
37
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
38
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
39
Nicotinamide Approved, Investigational, Nutraceutical Phase 2 98-92-0 936
40
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
41
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
42
leucovorin Approved, Nutraceutical Phase 2 58-05-9 143 6006
43 Exatecan Investigational Phase 2 171335-80-1
44
Camptothecin Experimental Phase 2 7689-03-4
45
Saracatinib Investigational Phase 2 379231-04-6
46 Soblidotin Investigational Phase 2 149606-27-9
47
protease inhibitors Phase 2
48 Cytochrome P-450 CYP3A Inhibitors Phase 2
49 HIV Protease Inhibitors Phase 2
50 Cytochrome P-450 Enzyme Inhibitors Phase 2

Interventional clinical trials:

(show all 46)
# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
3 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
4 Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Completed NCT00091351 Phase 3
5 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
6 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
7 Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00061984 Phase 3 doxorubicin hydrochloride;ifosfamide
8 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3 doxorubicin hydrochloride;etoposide;ifosfamide
9 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
10 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Recruiting NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
11 Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Recruiting NCT01344018 Phase 3
12 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
13 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
14 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
15 Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma Unknown status NCT00410462 Phase 2 brostallicin;doxorubicin hydrochloride
16 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
17 Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Completed NCT00400569 Phase 2 Sunitinib Malate (SU011248)
18 Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma Completed NCT00031915 Phase 2 imatinib mesylate
19 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
20 Bevacizumab and Radiation Therapy for Sarcomas Completed NCT00356031 Phase 2 Bevacizumab
21 Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung Completed NCT00503295 Phase 2
22 Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma Completed NCT00085475 Phase 2 imatinib mesylate
23 AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2 saracatinib
24 Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Completed NCT00245102 Phase 2 sorafenib tosylate
25 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
26 Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Completed NCT00949325 Phase 1, Phase 2 temsirolimus (Torisel) plus liposomal doxorubicin (Doxil)
27 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
28 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Completed NCT00526149 Phase 2 BI 2536
29 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
30 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
31 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
32 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
33 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
34 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Active, not recruiting NCT00667342 Phase 2 Cisplatin;Doxorubicin;Methotrexate;Ifosfamide;etoposide
35 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
36 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
37 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
38 Vaccine Therapy in Treating Patients With Metastatic Cancer Completed NCT00020267 Phase 1 interleukin-2;MAGE-12 peptide vaccine;Montanide ISA-51
39 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
40 Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX Unknown status NCT00900211
41 Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone Completed NCT00007046
42 Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy Completed NCT01674101 Not Applicable
43 Optical Biopsy of Human Skin in Conjunction With Laser Treatment Completed NCT00540566
44 Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas Recruiting NCT03392935 Not Applicable
45 PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma Active, not recruiting NCT00346125 Not Applicable doxorubicin hydrochloride;ifosfamide;pegylated liposomal doxorubicin hydrochloride
46 Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma Withdrawn NCT00334984 Not Applicable glutamine

Search NIH Clinical Center for Fibrous Histiocytoma

Cochrane evidence based reviews: histiocytoma, benign fibrous

Genetic Tests for Fibrous Histiocytoma

Anatomical Context for Fibrous Histiocytoma

MalaCards organs/tissues related to Fibrous Histiocytoma:

41
Bone, Skin, Lung, Breast, Liver, Heart, Colon

Publications for Fibrous Histiocytoma

Articles related to Fibrous Histiocytoma:

(show top 50) (show all 889)
# Title Authors Year
1
Giant malignant fibrous histiocytoma of the testis. ( 29484233 )
2018
2
Retroperitoneal Angiomatoid Fibrous Histiocytoma Presenting as a Recurrent Spontaneous Retroperitoneal Hemorrhage in a 9-Year-Old Boy. ( 29432314 )
2018
3
Primary intracranial angiomatoid fibrous histiocytoma: a case report and literature review. ( 29540076 )
2018
4
ALK Expression in Angiomatoid Fibrous Histiocytoma: A Potential Diagnostic Pitfall. ( 29877921 )
2018
5
Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. ( 29932283 )
2018
6
Giant Aneurysmal Benign Fibrous Histiocytoma (Dermatofibroma). ( 29956351 )
2018
7
Low-Grade Malignant Fibrous Histiocytoma Originating From the Medial Rectus Muscle. ( 29538190 )
2018
8
Angiomatoid Fibrous Histiocytoma With Paraneoplastic Platelet Storage Pool Deficiency. ( 29472492 )
2018
9
A subset of so-called dermal non-neural granular cell tumours are underlined by ALK fusions, further supporting the idea that they represent a variant of epithelioid fibrous histiocytoma. ( 29742298 )
2018
10
Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases. ( 29327718 )
2018
11
ALK Gene Fusions in Epithelioid Fibrous Histiocytoma: A Study of 14 Cases, With New Histopathological Findings. ( 29329131 )
2018
12
"Chondroblastoma-like" epithelioid fibrous histiocytoma: A previously undescribed and potentially confusing variant. ( 29068085 )
2018
13
Fibrous Histiocytoma of the Lacrimal Sac in an 11-Year-Old Male. ( 29494378 )
2018
14
Unusual Uptake of 131I in a Cutaneous Benign Fibrous Histiocytoma in a Patient With Thyroid Cancer. ( 29076899 )
2018
15
ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review. ( 29788195 )
2018
16
Primary Hepatic Malignant Fibrous Histiocytoma on PET/CT. ( 29485437 )
2018
17
Spindle cell predominant epithelioid fibrous histiocytoma. ( 29430713 )
2018
18
A Case of Angiomatoid Fibrous Histiocytoma Presenting as Subcutaneous Nodule in a 4-Year-Old Girl. ( 29606824 )
2018
19
Intracranial malignant fibrous histiocytoma. ( 29685317 )
2018
20
Treatment outcomes of malignant fibrous histiocytoma of the maxillary sinus. ( 28901310 )
2017
21
Malignant fibrous histiocytoma masquerading as pyogenic granuloma. ( 28388346 )
2017
22
Primary Pulmonary Malignant Fibrous Histiocytoma. ( 29404161 )
2017
23
Primary pulmonary malignant fibrous histiocytoma: case report and literature review. ( 28932590 )
2017
24
Benign Fibrous Histiocytoma: An Uncommon Presentation. ( 28892910 )
2017
25
18F-FDG Uptake in Benign Fibrous Histiocytoma of Adrenal Gland: A Potential Pitfall. ( 28632691 )
2017
26
Deep Benign Fibrous Histiocytoma of the Anterior Mediastinum Mimicking Malignancy. ( 28497381 )
2017
27
TLE-1-Positive Angiomatoid Fibrous Histiocytoma Mimicking Synovial Sarcoma. ( 28248724 )
2017
28
Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck. ( 28988458 )
2017
29
Malignant fibrous histiocytoma in the right portion of the mandible with metastasis in pancreas. ( 29040904 )
2017
30
Angiomatoid fibrous histiocytoma of the scalp mimicking cutaneous angiosarcoma in incisional biopsy containing CD31-positive histiocytes: A potential histopathological pitfall. ( 28370384 )
2017
31
Aneurysmal Variant of Fibrous Histiocytoma- A Rare Entity Known for Recurrence. ( 28764178 )
2017
32
Malignant fibrous histiocytoma arising from renal capsule: An extremely rare entity. ( 28937382 )
2017
33
En bloc resection and prosthesis implantation to treat malignant fibrous histiocytoma of the humerus. ( 29068573 )
2017
34
Cholesterotic Fibrous Histiocytoma in a Patient with Metabolic Syndrome. ( 29033817 )
2017
35
Primary hepatic malignant fibrous histiocytoma combined with invasion of inferior vena cava: A case report and literature review. ( 28591058 )
2017
36
Retrovesical malignant fibrous histiocytoma: a rare tumor. ( 29197849 )
2017
37
Two cases of benign fibrous histiocytomas (dermatofibromas) associated with Langerhans cell histiocytosis. ( 28941307 )
2017
38
CORR Insights(Ar): Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. ( 28656494 )
2017
39
Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. ( 28536856 )
2017
40
Aneurysmal fibrous histiocytoma - spindle cell tumour with pigment: A diagnostic dilemma on cytology. ( 28727241 )
2017
41
Dermoscopy and reflectance confocal microscopy of osteoclastic deep benign fibrous histiocytoma. ( 28895663 )
2017
42
Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? ( 28281318 )
2017
43
Dermoscopic findings in an early malignant fibrous histiocytoma on the face. ( 29085719 )
2017
44
Cholesterotic fibrous histiocytoma with no associated dyslipidemia. ( 28303567 )
2017
45
A Rare Case of Malignant Fibrous Histiocytoma (Undifferentiated High-Grade Pleomorphic Sarcoma) of Malar Region. ( 28468216 )
2017
46
Malignant fibrous histiocytoma in a patient presenting with urinary system symptoms. ( 29451657 )
2017
47
Benign Fibrous Histiocytoma: A Rare Case Report and Literature Review. ( 26929563 )
2016
48
Double primary malignant fibrous histiocytoma and squamous cell carcinoma of the larynx treated with laser laryngeal conservation surgery. ( 27170836 )
2016
49
Benign Fibrous Histiocytoma of the Frontal Bone. ( 27054431 )
2016
50
Fibrous Histiocytoma of the Conjunctiva. ( 27636240 )
2016

Variations for Fibrous Histiocytoma

Expression for Fibrous Histiocytoma

Search GEO for disease gene expression data for Fibrous Histiocytoma.

Pathways for Fibrous Histiocytoma

Pathways related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.53 ATF1 EWSR1 FUS MITF
2 11.19 ACTC1 DES VIM
3 10.54 ATF1 CREB1
4 10.34 ATF1 CREB1 MITF

GO Terms for Fibrous Histiocytoma

Biological processes related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 intermediate filament organization GO:0045109 8.96 DES VIM
2 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transcription coregulator activity GO:0003712 9.33 CREB1 EWSR1 FUS
2 identical protein binding GO:0042802 9.17 ATF1 CREB1 DES EWSR1 FUS S100B
3 transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding GO:0003705 9.13 ATF1 CREB1 MITF

Sources for Fibrous Histiocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....